PMA supplement
P120016 S039: VASCADE MVP XL VVCS Model 800-1014XL
FDA PMA supplement · Panel Track · Cardiva Medical, Inc.
Key facts
| Original PMA | P120016 |
|---|---|
| Supplement number | S039 |
| Supplement type | Panel Track |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | VASCADE MVP XL VVCS Model 800-1014XL |
| Generic name | Device, hemostasis, vascular |
| Applicant | Cardiva Medical, Inc. |
| Product code | MGB |
| Received date | Sep 30, 2025 |
| Decision date | Mar 27, 2026 |
At a glance
- No Expedited review granted
- Yes Approval order on file
- Yes Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: